$CLPT 0.36 Noisy
- Date
- Aug 2, 2026
- Mentions
- 1
- Unique authors
- 1
- Sector
- semiconductors
- Stance
- bullish
- On card
- no
Sentiment history
No sentiment history available for $CLPT yet.
Sentiment
Notable posts
-
neutral 1283 eng
10 SMALL-CAP NAMES UNDER $5B WORTH WATCHING 1. $CLPT navigation platform for neurosurgeons 2. $OSS rugged edge compute for the battlefield 3. $OUST eyes & perception for physical AI machines 4. $NVTS GaN power for $NVDA 800V data center shift 5. $AMBQ ultra-low-power silicon for always-on edge AI 6. $AMBA edge AI vision chips for cameras, cars & robots 7. $TMDX expanding organ care with fleet & network effect 8. $TE building America's solar supply chain from cell to module 9. $AEHR wafer-level burn-in for photonics, HBM & high-power AI chips 10. $ONDS autonomy & counter-drone systems for the modern battlefield
view on X → -
bullish 1116 eng
NEXT WEEK’S EARNINGS ARE MASSIVE FOR GROWTH • Monday | $PLTR, $CLPT, $ON, $GRAB, $SNAP, $WGS, $VOYG • Tuesday | $AMD, $SPCX, $CIFR, $ZETA, $ANET, $ALAB, $TMDX, $KTOS, $DOCN, $HUT, $OPEN, $PRCT • Wednesday | $SNDK, $APP, $IONQ, $MELI, $UBER, $SHOP, $EOSE, $OSS, $VPG, $DUOL, $FIG, $SYM, $RDW, $FLNC, $VIAV • Thursday | $CELH, $DDOG, $OSCR, $NET, $TTD, $U, $QBTS, $AAOI, $RCAT, $TEAM, $OUST, $SHAZ • Friday | $OKLO, $VST
view on X → -
neutral 910 eng
10 SMALL-CAP NAMES UNDER $2B WORTH WATCHING 1. $JMIA scaling logistics across Africa 2. $CLPT navigation software for neurosurgeons 3. $EOSE zinc storage built for nonstop compute 4. $OSS rugged edge compute for the battlefield 5. $CLFD fiber infrastructure for edge data centers 6. $AMBQ low-power silicon for edge AI robots & devices 7. $VPG force sensing & precision measurement for robots 8. $TE building America’s solar supply chain from cell to module 9. $KRKNF underwater robotics for defense & offshore infrastructure 10. $BZAI edge AI inference platform for real-world autonomous systems
view on X → -
bullish 150 eng
$CLPT is up 34% after the FDA allowed $QURE to use three-year Phase I/II AMT-130 data as primary basis for an accelerated approval BLA filing planned for Q3 2026. ClearPoint is moving because AMT-130 is delivered directly into the brain using its navigation system and SmartFlow cannula meaning every trial procedure and potentially every commercial procedure if approved runs through its platform.
view on X → -
neutral 125 eng
uniQure $QURE says FDA feedback supports using 3-year Phase I/II AMT-130 data as the primary basis for a BLA seeking accelerated approval in Huntington’s disease. BLA planned for Q3 2026. ClearPoint $CLPT is also moving as AMT-130 is delivered using its navigation system and SmartFlow cannula.
view on X → -
neutral 31 eng
Tenet Pre-Market Movers June.17.26 $QURE $CLPT $NEOV $LZB $MNTS $MCRP $AEHR $ACMR $PDYN $ASTS $ASML $KMX $INTC $ABCL $MU $AMD $VSTM $OUST $SOFI $MYSE $YQ $IMDX $LION $SOPH $JBL @ripster47 | @tenet_research | @TenetCharts https://t.co/wY29QBvqXP
view on X → -
neutral 20 eng
Tenet Market Wake-Up Summary 📷📷 June.17.26 $SPX $AMZN $ASTS $INTC $OUST $SMR $HOOD $COIN $NFLX $AEHR $ORCL $MSFT $MNTS $IONQ $KTOS $LZB $JBL $KMX $CRL $MAC $HUN $ALGT $IQV $RMD $ZGN $LDOS $QURE $CLPT $MYSE $YQ $IMDX @ripster47 | @TENETTRADEGROUP | @TenetCharts https://t.co/UZqrXoliGx
view on X →
Signal history
| Date | Score | Signal | Mentions | Rank |
|---|---|---|---|---|
| 2026-06-17 | 0.61 | Developing | 4 | — |
| 2026-06-27 | 0.46 | Noisy | 1 | — |
| 2026-07-11 | 0.43 | Noisy | 1 | — |
| 2026-08-02 | 0.36 | Noisy | 1 | — |